| 000 | 00441nam a2200133 4500 | ||
|---|---|---|---|
| 090 |
_a167277 _9167276 |
||
| 010 | _bbr. | ||
| 012 | _210009775 | ||
| 100 | _a20190416d u||y0frey50 ba | ||
| 101 | _aeng | ||
| 200 |
_aguidelines for drug susceptibility testing. _bLIVR _efor second-line anti-tuberculosis drugs for dots-plus. _fworld health organization. |
||
| 205 | _aworld health organization. | ||
| 210 |
_as.l. _ddl.imp.cop.2001. |
||
| 215 |
_a1vol.(12). _d30cm. |
||